Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Paraneoplastic Cerebellar Degeneration

ClinicalTrials.gov lists 1 trial for Paraneoplastic Cerebellar Degeneration or a narrower condition beneath it.

MeSH D020362 Neoplasms Neoplasm C04 C10 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Prevalence Prevalence 18 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Prevalence Prevalence 18 Rare-disease identity Rare-disease identity 2

Rows recorded per section

4 sections measured, none recorded · 1 not measured yet · 1 not computed

1 of the 1 trial is tagged with Paraneoplastic Cerebellar Degeneration itself; the rest are tagged with a narrower condition beneath it.

Get the Paraneoplastic Cerebellar Degeneration report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Paraneoplastic Cerebellar Degeneration trials start? (1)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2020 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Paraneoplastic Cerebellar Degeneration trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Observational 1

How many Paraneoplastic Cerebellar Degeneration trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Prevalence (18)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Paraneoplastic cerebellar degeneration Annual incidence 1-9 / 1 000 000 Europe Not stated Exact
Paraneoplastic cerebellar degeneration Point prevalence 1-9 / 100 000 Italy Not stated Exact
Paraneoplastic cerebellar degeneration Point prevalence 1-9 / 1 000 000 France Not stated Exact
Paraneoplastic cerebellar degeneration Point prevalence 1-9 / 1 000 000 France Not stated Unspecified
Paraneoplastic cerebellar degeneration Annual incidence 1-9 / 1 000 000 Italy Not stated Unspecified

Showing 5 of 18 prevalence observations.

Start your 14-day trial Email me all 18 prevalence observations as a PDF

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Paraneoplastic cerebellar degeneration 623626 Exact Orphadata Science knowledge files, Product 1
Paraneoplastic cerebellar degeneration 623626 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, publications, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages